The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study
- PMID: 31056618
- PMCID: PMC6535166
- DOI: 10.15537/smj.2019.5.24162
The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study
Abstract
Objectives: To evaluate p63 expression pattern in Saudi colorectal cancer (CRC) patients and correlate that with clinicopathological parameters and its role in carcinogenesis and prognosis.
Methods: Archival tumor samples were analyzed by immunohistochemistry for p63 expression in 324 consecutive Saudi patients diagnosed with CRC between January 2006 and December 2017 at the Pathology Department of a tertiary care Hospital, Madinah, Saudi Arabia.
Results: P63 over-expression was absent in normal mucosa, while 12.5% cases of adenoma showed its over-expression. In CRC, p63 expression was high in 24.1% of cases. There were no significant correlations between p63 expression and gender, tumor location, tumor size and tumor histologic differentiation. However, high p63 expression revealed a significant correlation with age (p=0.035), tumor type (p=0.004), American Joint Committee on Cancer stage (p=0.046), lymph node metastasis (p=0.006), lymphovascular invasion (p=0.006), distant metastasis (p=0.049), high Ki67 expression (p=0.000) and K-ras expression (p=0.002). The Kaplan-Meier analysis revealed a shorter period of survival with p63 over-expression (p less than 0.001). The Cox-regression model analysis showed that p63 over-expression was an independent prognostic marker in CRC (p=0.000).
Conclusion: P63 expression was increased from normal to adenoma to carcinoma sequence. Moreover, p63 cytoplasmic expression seems to be related to high Ki67 indexing, K-ras expression, advanced tumor stage and poor clinical outcome of CRC. These findings suggest a significant role of cytoplasmic p63 expression in tumor progression and prognosis.
Figures
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN. Cancer incidence and mortality worldwide. Lyon (FR): International Agency for Research on Cancer; 2012.
-
- Bray F, Ren JS, Masuyer E, Ferlay J. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–1145. - PubMed
-
- Saudi Health Council. Annual Cancer Incidence Report for Saudi Cancer Registry (SCR) [(Updated 2014; Accessed 2018 November 11)]. Available from https://nhic.gov.sa/eServices/Documents/2014.pdf .
-
- Albasri A, Yosef H, Hussainy AS, Sultan SA, Alhujaily A. Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia:8 years experience. Asian Pac J Cancer Prev. 2014;15:3133–3137. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
